Codexis, Inc. To Present At ROTH Conference
REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster will present at the 27th Annual ROTH Conference on Tuesday, March 10, 2015, at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). The conference is being held at the Ritz-Carlton Laguna Niguel in Dana Point, Calif.
A live webcast and replay will be available on the Investors section of the company's website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. Codexis' proven technology enables scale-up and implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable process development – from research to manufacturing. For more information, see www.codexis.com.
| CONTACT: | Investors |
| LHA | |
| Jody Cain, 310 691 7100 | |
| jcain@lhai.com | |
| Media | |
| Notch Communications | |
| Kate Whelan, +46 (0)70 238 11 49 | |
| Kate.whelan@notchcommunications.co.uk |
Help employers find you! Check out all the jobs and post your resume.